SouthernWorldwide.com – A large-scale study has revealed that switching from traditional cigarettes to electronic vapes may lead to an increased risk of developing major eye diseases when compared to quitting nicotine entirely.
The research, conducted by scientists at the Korea University College of Medicine in Seoul, South Korea, analyzed health insurance data from a significant cohort of 179,273 adults. This data was sourced from the Korean National Health Insurance Service.
All individuals included in the study had a history of smoking conventional cigarettes between the years 2011 and 2012. Crucially, they had all ceased smoking by either 2018 or 2019, according to the study’s parameters.
To ensure the validity and fairness of the comparison, the researchers meticulously matched participants. This matching process considered factors such as age, gender, pre-existing medical conditions, and general lifestyle habits, creating a balanced control group.
This careful selection resulted in a balanced group of 32,316 participants. These individuals were then divided into two distinct categories: those who completely stopped using all nicotine products and those who transitioned to smokeless nicotine alternatives, such as e-cigarettes or vapes.
The study tracked these participants for an average duration of 4.6 years. During this follow-up period, the researchers monitored for the development of various serious eye conditions. These included cataracts, glaucoma, age-related macular degeneration, diabetic retinopathy, and vision disorders related to focusing difficulties.
Over the course of the tracking period, the participants collectively experienced 6,328 instances of major eye diseases. The group that abstained from all nicotine products entirely demonstrated the lowest incidence rate of these conditions.
Specifically, those who quit nicotine completely had a disease rate of 41.1 cases per 1,000 person-years. This metric accounts for both the number of individuals in the study and the length of time they were observed.
In contrast, the rate of major eye diseases was higher among individuals who had switched to smokeless nicotine alternatives like vapes. Their rate stood at 44 cases per 1,000 person-years.
The data ultimately indicated that the act of switching to alternative nicotine products was associated with a consistent 7% elevated risk of developing serious eye diseases when directly compared to individuals who had quit nicotine altogether.
The findings were particularly pronounced in specific conditions. Those who switched to vapes faced a significantly higher risk of developing diabetic retinopathy, a condition that causes damage to the blood vessels in the retina, the light-sensitive tissue at the back of the eye.
The increased risk for diabetic retinopathy among vapers was found to be 24% higher than for complete quitters. Furthermore, individuals who substituted cigarettes with vapes also experienced a 7% higher risk of developing refractive and accommodation disorders, which impair the eye’s ability to focus light accurately.
“These findings challenge the prevailing assumption that substituting noncombustible nicotine or tobacco products for conventional cigarettes is visually harmless,” the researchers stated in their findings.
The authors acknowledged certain limitations inherent in their research methodology. Given that this study relied on retrospective analysis of health insurance data, it cannot definitively establish a direct causal link between vaping and eye damage.
Additionally, the study’s reliance on self-reported questionnaires regarding smoking and vaping habits introduced potential for inaccuracies. Such self-reporting can sometimes lead to underreporting of usage or simple memory lapses on the part of participants.
Despite these limitations, the researchers concluded that their findings strongly suggest that replacing cigarettes with alternative nicotine products may not fully mitigate the risk of developing certain types of eye diseases.
